CENTRE ANTOINE LACASSAGNE
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- -
- Established
- 1961-01-01
- Employees
- -
- Market Cap
- -
Stereotaxic Body Irradiation of Oligometastase in Sarcoma (Stereosarc)
- First Posted Date
- 2018-06-07
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 103
- Registration Number
- NCT03548428
- Locations
- 🇫🇷
Institut Paoli CALMETTES, Marseille, France
🇫🇷Institut de cancérologie de Montpellier, Montpellier, France
🇫🇷Centre Antoine LACASSAGNE, Nice, France
Phase I Trial of CArbonic Anhydrase Inhibition in Combination with Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma
Phase 1
Recruiting
- Conditions
- Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2018-03-16
- Last Posted Date
- 2025-01-03
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 30
- Registration Number
- NCT03467360
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly Chemotherapy
Phase 2
Completed
- Conditions
- Locally Advanced Non-small Cell Lung Cancer
- Interventions
- First Posted Date
- 2017-12-13
- Last Posted Date
- 2017-12-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 44
- Registration Number
- NCT03371550
Study of Metabolites Markers in Adjuvant Breast Cancer
Completed
- Conditions
- Breast Neoplasms
- First Posted Date
- 2017-12-08
- Last Posted Date
- 2017-12-08
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 52
- Registration Number
- NCT03367208
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, Cedex 2, France
Cetuximab for Unresectable Cutaneous Squamous Cell Carcinoma - A National Retrospective Study
Completed
- Conditions
- Squamous Cell Cutaneous Carcinoma of the Skin
- First Posted Date
- 2017-10-30
- Last Posted Date
- 2019-01-31
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 60
- Registration Number
- NCT03325738
- Locations
- 🇫🇷
PEYRADE Frédéric, Nice, France
The Enzymatic Activity of Lymphocyte Dihydropyrimidine Dehydrogenase DPD in the Blood as a Predictive and Prognostic Factor in Patients With Digestive Cancer in the First or Second Metastatic Line
- Conditions
- Metastatic or Locally-advanced Digestive Cancer
- Interventions
- Diagnostic Test: lymphocyte DPD dosage
- First Posted Date
- 2017-07-02
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 200
- Registration Number
- NCT03205735
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
High Intensity Focused Ultrasound Guided by MRI as Thermic Destruction in Primitive Small Size Breast Cancer
Not Applicable
Withdrawn
- Conditions
- Breast Cancer
- Interventions
- Procedure: HIGH INTENSITY FOCUSED ULTRASOUND
- First Posted Date
- 2017-04-24
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Centre Antoine Lacassagne
- Registration Number
- NCT03126487
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
Technique of Per-Operative Radiotherapy (RPO) by Papillon +TM in Localized Breast Cancer
Not Applicable
Active, not recruiting
- Conditions
- Localized Breast Cancer
- Interventions
- Device: Papillon +TM
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2025-02-19
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 47
- Registration Number
- NCT03121469
- Locations
- 🇫🇷
Centre Antoine Lacassagne, Nice, France
18F-FDG PET Scan and MRI Diffusion.Evaluation of the Early Therapeutic Response of Diffuse Large B-cell Lymphoma
Not Applicable
Active, not recruiting
- Conditions
- Diffuse Large B Cell Lymphoma
- Interventions
- Other: 18F-FDG PET SCANOther: MRI DIFFUSION
- First Posted Date
- 2017-04-20
- Last Posted Date
- 2023-11-13
- Lead Sponsor
- Centre Antoine Lacassagne
- Target Recruit Count
- 74
- Registration Number
- NCT03121456
- Locations
- 🇫🇷
Centre antoine-LACASSAGNE, Nice, France
Pembrolizumab and Induction Chemotherapy in Head and Neck Squamous Cell Carcinoma (PICH Study)
Phase 1
Withdrawn
- Conditions
- Head and Neck Squamous Cell Carcinoma (HNSCC)
- Interventions
- Drug: TPF2Other: Radiotherapy with carboplatin
- First Posted Date
- 2017-04-14
- Last Posted Date
- 2019-04-08
- Lead Sponsor
- Centre Antoine Lacassagne
- Registration Number
- NCT03114280
- Locations
- 🇫🇷
PEYRADE Frédéric, Nice, France
© Copyright 2025. All Rights Reserved by MedPath